










































Protein Modification via Alkyne Hydrosilylation Using A
Substoichiometric Amount of Ruthenium(II) Catalyst
Citation for published version:
Kwan, TT-L, Boutureira, O, Frye, EC, Walsh, SJ, Gupta, MK, Wallace, S, Wu, Y, Zhang, F, Sore, HF,
Galloway, WRJD, Chin, JW, Welch, M, Bernardes, GJL & Spring, DR 2017, 'Protein Modification via Alkyne
Hydrosilylation Using A Substoichiometric Amount of Ruthenium(II) Catalyst' Chemical Science, vol 8, no. 5,
pp. 3871-3878. DOI: 10.1039/C6SC05313K
Digital Object Identifier (DOI):
10.1039/C6SC05313K
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
https://creativecommons.org/licenses/by/3.0/
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 07. Jul. 2018
Protein modiﬁcation via alkyne hydrosilylation
using a substoichiometric amount of ruthenium(II)
catalyst†‡
Terence T.-L. Kwan,a Omar Boutureira, a Elizabeth C. Frye,a Stephen J. Walsh,a
Moni K. Gupta,a Stephen Wallace,bc Yuteng Wu,a Fengzhi Zhang,a Hannah F. Sore,a
Warren R. J. D. Galloway,a Jason W. Chin,ab Martin Welch,d
Gonçalo J. L. Bernardes ae and David R. Spring *a
Transition metal catalysis has emerged as a powerful strategy to expand synthetic ﬂexibility of protein
modiﬁcation. Herein, we report a cationic Ru(II) system that enables the ﬁrst example of alkyne hydrosilylation
between dimethylarylsilanes and O-propargyl-functionalized proteins using a substoichiometric amount or
low-loading of Ru(II) catalyst to achieve the ﬁrst C–Si bond formation on full-length substrates. The reaction
proceeds under physiological conditions at a rate comparable to other widely used bioorthogonal reactions.
Moreover, the resultant gem-disubstituted vinylsilane linkage can be further elaborated through thiol–ene
coupling or ﬂuoride-induced protodesilylation, demonstrating its utility in further rounds of targeted
modiﬁcations.
Introduction
The chemical modication of biomolecules has emerged as
a powerful tool to study cellular systems.1–3 Alongside recombi-
nant methods,4–7 advances in organic chemistry have fueled the
development of an increasing number of chemical reactions
capable of modifying proteins at both genetically and chemically
predened sites.8–13 These bioorthogonal reactions have trans-
formed our ability to visualize cellular processes, and have
enabled the development of new therapeutic strategies to treat
diseases.14–16 Within this “toolbox” of bioorthogonal reactions,
transition metal-mediated reactions are arguably the most
underdeveloped.17–20 This is likely due to transition metals'
propensity for unproductive chelation within the biological
milieu, resulting in the need for high catalyst loadings to achieve
acceptable reaction rates and labeling eﬃciency (Fig. 1a).
Previous examples of transition metal-mediated reactions
include Cu(I) azide–alkyne cycloaddition,21,22 Ru(II) cross-
metathesis,23–26 Pd(II) cysteine bioconjugation,27 Suzuki–
Miyaura28,29 and some of their intracellular variants.30,31However,
most published reaction conditions utilize high catalyst loading
and the development of a truly catalytic transition metal-
mediated bioconjugation strategy has received little attention.
Here we report a new Ru-catalyzed alkyne hydrosilylation
reaction for protein modication. Using the water-soluble Ru
catalyst [Cp*Ru(MeCN)3]PF6 (1) and dimethylaryl hydrosilane
derivatives, this methodology enables the eﬃcient labeling of
multiple protein targets modied both stochastically and site-
Fig. 1 (a) General metal-mediated protein modiﬁcation protocols
using excess of metal catalysts and (b) our approach via Ru(II)-cata-
lyzed alkyne hydrosilylation.
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specically with an alkyne-containing moiety (Fig. 1b). In
addition, hydrosilylation has orthogonal chemical reactivity to
ketone-hydrazine condensation reaction in vitro, and the
resultant gem-disubstituted vinylsilane product can be further
modied via thiol–ene coupling and uoride-induced proto-
desilylation, demonstrating the potential of this methodology
for use in both orthogonal dual labeling and single-site,
multiple-probe imaging applications. To the best of our
knowledge, this represents the rst example of a C–Si bond
formation on protein substrates using substoichiometric or
low-loading of transitionmetal catalysts – a feature that we hope
will reinstate this mode of catalysis as a viable avenue for future
research in the eld.
Results and discussion
Although hydrosilylation has gained widespread utility in
organic synthesis and in the industrial production of organo-
silicon compounds,32–35 aqueous alkyne hydrosilylation is
largely underdeveloped. Inspired by the development of
a cationic ruthenium catalyst [Cp*Ru(MeCN)3]PF6 1 by Trost
and Ball,36,37 we examined the catalyst's ability to catalyze
hydrosilylation under biocompatible, aqueous conditions. We
started our investigation by reacting 3,6,9,12-tetraoxapentadec-
14-yne 2 as a model alkyne and a variety of water-soluble
hydrosilanes with 1 (5 mol%). Despite previously reported
reactivities of trialkoxy and trialkyl silanes, no vinylsilane
products were observed under the reaction conditions tested
(Table 1, entries 1–3).
Gratifyingly, hydrosilylation of dimethylaryl hydrosilane 4
with 2 proceeded smoothly (Table 1, entry 4), achieving full
conversion with 92% isolated yield in less than 5 min. This
apparent high reactivity may be attributed to the strong aﬃnity
for Cp*Ru complexes to coordinate with aromatic rings,37
allowing hydrosilylation to proceed rapidly in aqueous solution
and open air, thus reinforcing the use of aryldialkyl hydro-
silanes in further experiments. The reaction proceeded with
a 2nd order rate constant k2  1.0 M1 s1 (see ESI, Fig. S20‡),
which is comparable to Ru(II) cross-metathesis and strain-
promoted alkyne–azide cycloadditions. Furthermore, 4 was
found to be stable in buﬀered conditions at neutral pH, with
a half-life (t1/2) > 1 week (see ESI, Fig. S21‡).
One of the side reactions of aqueous hydrosilylation is the
hydrolysis of hydrosilane to form silanol (Si–OH). In an eﬀort to
reduce silanol formation, we installed substituents adjacent to
the Si–H bond with varying degree of steric hindrance
(compounds 5–7) in the hope to increase selectivity for hydro-
silylation over silanol formation. However, none of the tested
analogues gave better selectivity or reaction rates (Table 1,
entries 5–7). In particular, 6 and 7 showed incomplete conver-
sion despite prolonged reaction times (Table 1, entries 6 and 7).
The hydrophobicity of chemical probes and modications
oen require the use of organic co-solvents in the reaction
mixture. Alcohol-based solvents were found to be tolerated as
co-solvents in aqueous hydrosilylation and achieved similar
reaction rates to those using pure water (see ESI, Fig. S22‡).
Thus, the hydrosilylation of 2 with triethylene glycol
hydrosilane derivative 8 in 50% t-BuOH in phosphate buﬀered
saline (PBS) at pH 7.4 gave the corresponding vinylsilane in 99%
isolated yield (Table 1, entry 8). In the presence of human
plasma, the reaction initially proceeded extremely slowly and
gave only trace of product. It was suspected that 1 is inactive in
hydrosilylation due to nonproductive chelation to ruthenium in
10% human plasma. Remarkably, the addition of hippuric acid
(BzNHCH2CO2H) as an additive/ligand helped to stabilize the
Ru(II) complex from rapid exchange processes with, for
example, histidine38,39 and aspartic acid40 residues in plasma
protein and restored the activity of 1, with the corresponding
vinylsilane product isolated in a good yield (Table 1, entry 9).
This result demonstrates that our novel hydrosilylation meth-
odology for protein modication can proceed under physio-
logical conditions.
The scope of this reaction was further evaluated using
a variety of small molecule alkynes representative of amino
acids, carbohydrates, and hydrophobic drugs such as alkynes 9,
11–13 that may be considered substructural motifs of 3-O-
methyl-DOPA (3-OMD), which is one of the most important
metabolites of L-DOPA. We rst investigated whether nearby
chalcogens on the terminal alkyne group could increase the rate
of hydrosilylation. With no nearby coordinating groups, the
reaction with alkyne 9 proceeded slowly, requiring a long
Table 1 Optimisation of hydrosilylation conditions (alkoxy vs. alkyl/
aryl hydrosilanes)
Entry Silane (R3SiH) Conversion
a (%) t (min)
1 (EtO)3SiH NR O/N
2 (TMSO)3SiH NR O/N
3 NR O/N






a Determined by 1H-NMR using 4,4-dimethyl-4-silapentane-1-sulfonic
acid (DSS) as an internal standard. b Isolated yield. c 50% t-BuOH in
PBS (pH 7.4). d Reaction conducted in the presence of 10% human
plasma. e 10 mol% hippuric acid (BzNHCH2CO2H) as an additive. O/
N: overnight; NR: no reaction (>95% starting alkyne recovered).
3872 | Chem. Sci., 2017, 8, 3871–3878 This journal is © The Royal Society of Chemistry 2017





















































































reaction time to reach 68% yield (Table 2, entry 1). Contrary to
the reported chalcogen eﬀect in protein cross-metathesis,23,26 S-
propargyl 11 and Se-propargyl 12 inhibited hydrosilylation and
the respective vinylsilane products were not detected, despite
extended reaction times (Table 2, entries 2 and 3). Surprisingly,
O-propargyl 13 showed the most promise, aﬀording vinylsilane
14 in 91% isolated yield (Table 2, entry 4). This is likely due to
the intricate balance between ruthenium-coordination (X ¼ O)
and inhibition (X ¼ S, Se).
This observation was further conrmed by the decreasing
isolated yields when reacting PhMe2SiH 15 with O-propargyl-
serine 16, S-propargyl-cysteine 18, and Se-propargyl-
selenocysteine 20 derivatives (Table 2, entries 5–7). Nonethe-
less, hydrosilylation proceeded smoothly on amino acids 21 and
23, as well as alkyne-sugar derivative 25, aﬀording the corre-
sponding products in excellent isolated yields (Table 2, entries
8–10). These examples are of particular importance, as
strategies for the in vivo incorporation of such moieties into
proteins and cell-surface glycans have been developed.41–43 Full
conversion was also achieved on a model peptide 27 with bio-
tinylated hydrosilane 29, demonstrating the potential for Ru(II)
aqueous hydrosilylation protocol to modify more complex
biomolecules (Scheme 1). Furthermore, the stability of the
resulting gem-disubstituted vinylsilane moiety was assessed
under physiological conditions and in the presence of biolog-
ical thiols, with no observable degradation at 37 C for up to
24 h (see ESI, Fig. S24‡).
Biocompatible chemical transformations are oen most
powerful when used in conjunction with each other, allowing
for the site-specic incorporation of multiple chemical modi-
cations into a single biomolecule.44 Encouragingly, hydro-
silylation was found to be compatible with the widely used a-
substituted amine/carbonyl condensation,45–48 where O-prop-
argyl 13 reacted smoothly with hydrosilane 15 in the presence of
Table 2 Alkyne scope for aqueous hydrosilylation
Entry Silane (ArMe2SiH) Alkyne Product
a (yield%)
1b 8 10 (68%)
2 8 NR
3 8 NR
4 8 14 (91%)
5c PhMe2SiH (15) 17 (98%)
6c 15 19 (29%)
7c 15 NR
8c 8 22 (85%)
9c 8 24 (81%)
10 8 26 (82%)
a Isolated yield. b 5 h reaction time. c 10 mol% hippuric acid added as an additive. NR: no reaction (>95% starting alkyne recovered).
This journal is © The Royal Society of Chemistry 2017 Chem. Sci., 2017, 8, 3871–3878 | 3873





















































































ketone 30, achieving >95% conversion to desired vinylsilane 31
in 30 min. Subsequent addition of hydrazine 33 resulted in
complete conversion of 30 to hydrazone 32. This demonstrates
the utility of tandem hydrosilylation and condensation reac-
tions via a step-wise, one-pot ligation strategy without any
undesired interference to their reactivities (Scheme 2a).
Most site-selective dual-labeling eﬀorts require the incorpo-
ration of two unique bioorthogonal functional groups49,50 or the
use of bifunctional substrates,51,52 which can be a synthetic
challenge and limits the wide adoption of such methods.
Moreover, it would be advantageous to have the ability to
selectively remove synthetically incorporated chemical modi-
cations, allowing for potential “switch on/oﬀ” applications. To
address these issues, we sought to further elaborate the gem-
disubstituted vinylsilane linkage via radical thiol–ene53–55 and
uoride-induced protodesilylation reactions56,57 (Scheme 2b).
To illustrate the dual-labeling methodology, we incubated
model vinylsilane substrate 31 with benzyl mercaptan, 10 mol%
2,2-dimethoxy-2-phenylacetophenone (DMPA) and irradiated at
365 nm to give doubly-modied derivative 34 in excellent iso-
lated yield (81%). Furthermore, the gem-disubstituted vinyl-
silane linkage can be cleaved by treatment with TBAF to give the
corresponding O-allyl 35, demonstrating the potential for
chemical Si-modications installed via hydrosilylation to be
selectively removed.
Scheme 1 Hydrosilylation of peptide 27 with biotinylated hydrosilane 29. aConversion (%) determined by HPLC.
Scheme 2 (a) Tandem hydrosilylation and hydrazine condensation reaction. (b) gem-Disubstituted vinylsilane reactivity under thiol–ene
coupling conditions and ﬂuoride-induced protodesilylation, giving thioether 34 and O-allyl 35 in 81% and 85% isolated yields, respectively.
aConversion (%) determined by HPLC.
3874 | Chem. Sci., 2017, 8, 3871–3878 This journal is © The Royal Society of Chemistry 2017





















































































With these promising results in hand, we conducted protein-
labeling experiments via hydrosilylation on diﬀerent protein
systems. First, lysine residues on lysozyme (Lyz) were non-
selectively modied with 36 to give O-propargyl modied Lyz
(OP-Lyz) (Fig. 2a and b). When treated with biotinylated
hydrosilane 29 and only 10 mol% of 1, we were pleased to
observe selective labeling of OP-Lyz over Lyz with negligible
background labeling (Fig. 2c). Similarly, when the reaction time
or concentration of 29 was held constant (1 h and 250 mM,
respectively), dose- and time-dependent labeling was observed,
even at very low catalyst loading (2 mol%) (see ESI, Fig. S1‡).
Inductively coupled plasma-mass spectrometry (ICP-MS) deter-
mined that ruthenium content was <10 ppb aer purication
when using 10 mol% catalyst (see ESI‡ for details). To the best
of our knowledge this result is the rst demonstration of
a protein modication protocol mediated by a sub-
stoichiometric amount of transition metal catalyst.
Next, we incorporated O-propargyl groups site-specically
into a super-folder GFP (sfGFP) protein (Fig. 2d).58 Briey,
PylRS/pylT pair, the wild-type orthogonal Methanosarcina bar-
keri pyrrolysyl-tRNA synthetase and tRNACUA pair and C-
terminally hexahistidine-tagged sfGFP containing an amber
codon (TAG) at position 150 (sfGFP150TAGHis6) were introduced
into E. coli. Addition of 37 (5 mM) led to the amino acid
dependent synthesis of full-length sfGFP-37150 in good yield
(15 mg L1 of culture). A similar approach was used to obtain
sfGFP-38150 as a negative control for labeling experiments
(Fig. S2 and S3‡). We subsequently incubated sfGFP-37150 with
uorescent hydrosilane 39 and 1 (5 mol%) in PBS (pH 7.4) at
37 C. A uorescent band was detected aer 24 h of incubation
with limited background uorescence observed. This result is
particularly noteworthy because no uorescence was observed
when sfGFP-38150 was reacted under the same conditions,
highlighting the bioorthogonality and specicity of this reac-
tion towards O-propargyl groups (Fig. 2e). The formation of the
expected ligated protein was further conrmed by LC-MS (see
ESI, Fig. S4‡).
As an alternative to recombinant techniques, we also site-
specically incorporated the alkyne handle through chemical
modications at cysteine. Using the methodology developed by
Davis and co-workers,59 the single cysteine mutant of the C2A
domain of Synaptotagmin I C2Am (eukaryotic marker of
apoptosis) was converted to OP-C2Am via the dehydroalanine-
tagged protein intermediate in >95% conversion (Scheme 3a).
Gratifyingly, 1 successfully mediated hydrosilylation of OP-
C2Am with 8 at 37 C for 1 h to aﬀord VS-C2Am as detected
Fig. 2 Selective labeling of O-propargyl (OP) modiﬁed protein substrates via hydrosilylation. (a) The structures of unnatural amino acids 37 and
38 and other reagents used in this study. (b) Modiﬁcation of solvent-exposed lysine residues on lysozyme (Lyz) with 36 and subsequent labeling
with 29. (c) Selective labeling of OP-Lyz via hydrosilylation with 29 and 1. Lyz () and OP-Lyz (+) (125 mM) was independently incubated with 29
(250 mM) and 1 (10 mol%) for 2 h at 37 C and the presence of biotinylated protein was detected by Western blot using a-biotin-HRP conjugated
antibody. (d) Genetic encoding and ﬂuorescent labeling of 37 via hydrosilylation. (e) In-gel ﬂuorescence demonstrating speciﬁc labeling of
sfGFP-37150 with 39. In (c) and (e), equal protein loading was veriﬁed by Coomassie staining.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci., 2017, 8, 3871–3878 | 3875





















































































by LC-MS (Scheme 3b). Compared to the high loading of tran-
sition metal complexes used in typical metal-mediated protein
modication protocols, Ru(II) complex 1 mediated aqueous
hydrosilylation oﬀers a milder alternative and these results
highlight its potential for site-specic chemical protein modi-
cation using either substoichiometric or low-catalyst loading
systems.
Having succinctly demonstrated the ability to carry out
alkyne hydrosilylation on numerous protein systems, eﬀorts
were then directed towards ascertaining whether it was possible
to modify the protein-incorporated vinylsilane through our
earlier described radical thiol–ene and protodesilylation reac-
tions. Vinylsilane-modied lysozyme (VS-Lyz) was chosen for
initial studies. We found that treatment of VS-Lyz with a pro-
tected cysteine amino acid and DMPA under hn irradiation
yielded Cys-Lyz, as detected by LC-MS (see ESI, Fig. S18‡).
Similarly, treatment of VS-Lyz with TBAF$3H2O aﬀorded Ene-
Lyz (see ESI, Fig. S19‡). These proof-of-principle experiments
show that the vinylsilane can be further modied aer its
introduction on a protein through Ru(II)-catalyzed aqueous
hydrosilylation.
Conclusions
In conclusion, we have demonstrated that O-propargyl groups
and dimethylaryl hydrosilanes (HSiMe2Ar) are eﬀective
coupling partners for Ru(II) complex 1 catalyzed aqueous
hydrosilylation, where alkyne-labeled small-molecules and
peptides are site-specically modied in good to excellent
yields. Furthermore, hydrosilylation is shown to have
orthogonal reactivity to the widely used bioorthogonal hydra-
zine condensation reaction, giving rise to potential biomolecule
dual-labeling applications. Furthermore, O-propargyl tagged
proteins (via chemical and genetic strategies) successfully
undergo site-specic hydrosilylation in the presence of sub-
stoichiometric or low loading of 1 to achieve the rst C–Si bond
on protein substrates. Finally, the resultant gem-disubstituted
vinylsilane linkage serves as a reactive chemical handle for
thiol–ene coupling and protodesilylation, highlighting the
potential for single-site dual-modication and the selective
removal of vinylsilane modications. Hence, we believe this
work greatly expands the reaction conditions and substrate
complexity of hydrosilylation and complements the growing
interest in metal-mediated protein modication strategies.
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